Home      Site Map      Contact      Links      Medical News      

fda fast track nda abraxane
Abraxane
Control your own health. Information on prescription drugs with LowPriceShopper!
On the Road to Recovery
Safe, natural medicine program For cancer patients. Find out more.
Abraxane
Control your own health. Save money on prescription drugs with LowPriceShopper!
Breville Premium Juicers
Find Powerful, Efficient Juicers & Blenders From BrevilleUSA.com.
abraxane Info
Get Info on abraxane from 14 search engines in 1.
abraxane
Discount abraxane - Compare Online and Save!
The Best Online Deals for abraxane
Find the Best Deals Here. Shop for abraxane now.
abraxane
Searching For abraxane? Find abraxane Resources & More!
abraxane
Searching For abraxane? Find abraxane Resources & More!
abraxane
Searching For abraxane? Find abraxane Resources & More!
fda fast track nda abraxane
American Pharmaceutical Partners and American BioScience Announce Filing of aNew Drug Application for FDA Approval of Abraxane for the Treatment of MetastaticBreast Cancer

First Biologically Interactive Protein Nanoparticle Chemotherapy Resulted inAlmost Doubling of Response Rate and Prolongation of Time to Tumor Progressionin Women With Metastatic Breast Cancer

SCHAUMBURG, Ill., March 8, 2004 -- American Pharmaceutical Partners, Inc fda fast track nda abraxane. (APP)and American BioScience, Inc fda fast track nda abraxane. (ABI) today announced that ABI has completed thefiling of a New Drug Application (NDA) to the U.S fda fast track nda abraxane. Food and Drug Administration(FDA) for Abraxane, for the treatment of metastatic breast cancer fda fast track nda abraxane. Using proprietarynanoparticle technology, Abraxane combines the active drug paclitaxel with anatural protein called albumin into a nanoparticle 1/100th the size of a redblood cell, avoiding the need for any solvent fda fast track nda abraxane. Abraxane is the first solvent-freenanoparticle albumin-bound chemotherapeutic, and may potentially exploit aninherent pathway for albumin receptor-mediated transport of drugs across endothelialcell walls of tumor neovasculature.

The NDA was submitted under the FDA's Fast Track designation, which was designedto facilitate the development of drugs for which there is an unmet medical need fda fast track nda abraxane. As part of the NDA filing, ABI has requested FDA to consider the applicationfor priority review designation, which if so designated, could potentially acceleratethe approval of Abraxane fda fast track nda abraxane. The filing of the NDA is based upon supportive PhaseI and II clinical trials of Abraxane and a pivotal randomized controlled PhaseIII trial that compared the safety and efficacy of 260 mg/m2 of Abraxane to175 mg/m2 of Taxol(R) administered every three weeks in 460 patients with metastaticbreast cancer fda fast track nda abraxane. The Phase III trial demonstrated that Abraxane resulted in analmost doubling of the response rate and a prolongation of time to tumor progressionin first and second line patients with metastatic breast cancer fda fast track nda abraxane. In addition,the study confirmed that Abraxane could be administered safely over 30 minuteswithout the need for steroid premedication.

This filing culminates a decade of preclinical and clinical research of Abraxaneas the first biologically interactive nanoparticle chemotherapy fda fast track nda abraxane. Preclinicalstudies demonstrated greater anti-tumor activity and higher intra- tumoral concentrationof Abraxane and these findings were predictive of the Phase III clinical results fda fast track nda abraxane. Potential explanations for these findings are provided by ongoing mechanisticstudies which suggest that the increased anti- tumor activity and increasedintra-tumoral concentration of the drug may be due, in part, to albumin-mediatedreceptor transport of the drug across the blood vessel wall into the tumor.

According to Patrick Soon-Shiong, M.D., Chairman, President and Chief ExecutiveOfficer of American Pharmaceutical Partners, "Targeting endothelial celltransport is a novel approach to increasing drug concentration in the tumorand provides the opportunity to exploit a natural biological pathway the malignantcell inherently uses to supply itself nutrients and energy for rapid growth fda fast track nda abraxane. Using this mechanism, the target would be shifted from the tumor cells themselvesto the specific albumin receptor on the blood vessel wall of the tumor neovasculature fda fast track nda abraxane. Abraxane represents the first example of the albumin-bound nanoparticle technologyplatform which may have the potential to exploit this natural biological pathway."

Abraxane was originally developed with the goal of addressing the toxicitiesassociated with the solvents Cremophor-EL and alcohol, used in Taxol fda fast track nda abraxane. Thesetoxicities required the need to premedicate patients with corticosteroids; requiredextended infusion times of Taxol; limited the dose of Taxol that could be administered;and, necessitated the use of specialized intravenous tubing sets to avoid leachingof plasticizers into the patient.

ABI and APP are strategic partners in the development, manufacture and marketingof Abraxane fda fast track nda abraxane. ABI is responsible for the clinical development and registrationof Abraxane fda fast track nda abraxane. APP has licensed the exclusive North American manufacturing andmarketing rights for Abraxane fda fast track nda abraxane. APP has taken a number of steps in preparingfor the launch of Abraxane, including forming a proprietary drug division, AbraxisOncology, and hiring a seasoned sales and marketing and medical affairs teamwith extensive experience in oncology fda fast track nda abraxane. APP has made significant strides in buildinga drug sales force and thus far has hired over 50 sales representatives withmajor pharmaceutical oncology experience.

About Breast Cancer
According to the American Cancer Society (ACS), while early detection effortshave decreased mortality rates, in 2003 more than 200,000 women were expectedto be diagnosed with breast cancer that had already spread fda fast track nda abraxane. Breast cancer isstill the leading overall cause of death in women between the ages of 20 and59, with almost 41,000 deaths associated with breast cancer each year fda fast track nda abraxane. One ofevery three cancers diagnosed in the United States is breast cancer; excludingskin cancer, it's the most common cancer among women.

About the Companies
American BioScience, Inc fda fast track nda abraxane. is a privately held biotechnology company focusedon the discovery, development and delivery of next-generation therapeutic moietiesincluding biologically active molecules already existing within the human biologicalsystem, for the treatment of life-threatening diseases fda fast track nda abraxane. American PharmaceuticalPartners, Inc fda fast track nda abraxane. is a majority owned subsidiary of American BioScience, Inc.

American Pharmaceutical Partners, Inc fda fast track nda abraxane. is a specialty drug company that develops,manufactures and markets injectable pharmaceutical products, focusing on theoncology, anti-infective and critical care markets fda fast track nda abraxane. APP has acquired the exclusiveNorth American rights to manufacture and market Abraxane(TM), a proprietarynanoparticle injectable oncology product that has completed Phase III clinicaltrials for metastatic breast cancer fda fast track nda abraxane. The company believes that it has establishedthe only commercial scale protein-engineered nanoparticle manufacturing capabilityin the United States.
fda fast track nda abraxane   abraxane aap   abraxane   abraxane   fda fast track nda abraxane   fda fast track nda abraxane   fda fast track nda abraxane   fda fast track nda abraxane   abraxane   abraxane aap   fda fast track nda abraxane   fda fast track nda abraxane   fda fast track nda abraxane   abraxane aap   fda fast track nda abraxane   abraxane aap   fda fast track nda abraxane   abraxane aap   abraxane aap   abraxane aap   abraxane aap   abraxane aap   abraxane aap   fda fast track nda abraxane   abraxane aap   abraxane aap   fda fast track nda abraxane   fda fast track nda abraxane   fda fast track nda abraxane   abraxane aap   fda fast track nda abraxane   abraxane aap   fda fast track nda abraxane   fda fast track nda abraxane   abraxane aap   fda fast track nda abraxane   abraxane aap   abraxane aap   abraxane   abraxane aap   abraxane aap   abraxane aap   abraxane aap   fda fast track nda abraxane   abraxane   abraxane aap   abraxane aap   fda fast track nda abraxane   abraxane   fda fast track nda abraxane   fda fast track nda abraxane   abraxane aap   fda fast track nda abraxane   abraxane   abraxane   fda fast track nda abraxane   fda fast track nda abraxane   abraxane   fda fast track nda abraxane   abraxane aap   abraxane aap   abraxane aap   fda fast track nda abraxane   fda fast track nda abraxane   abraxane   abraxane   abraxane aap   fda fast track nda abraxane  
abilify  abraxane  accolate  accupril  accutane  acetaminophen  aciphex  aclovate  actifed  activase  actiza  actonel  actos  aczone  adacel  adalat  adderall  adipex  advair  advate  agilect  albalon  albuterol  aldomet  alesse  aleve  alimta  allegra  aloxi  alphagan  alprazolam  altace  altocor  alvesco  amaryl  ambien  amiodarone  amitriptyline  amoxicillin  androgel  angeliq  anidulafungin  antabuse  antegren  anusol  apidra  apokyn  arthrotec  asacol  aspirin  atenolol  ativan  augmentin  avandia  avapro  avastin  avelox  axid 
ffda fast track nda abraxane fdda fast track nda abraxane fdaa fast track nda abraxane fda fast track nda abraxane fda ffast track nda abraxane fda faast track nda abraxane fda fasst track nda abraxane fda fastt track nda abraxane fda fast track nda abraxane fda fast ttrack nda abraxane fda fast trrack nda abraxane fda fast traack nda abraxane fda fast tracck nda abraxane fda fast trackk nda abraxane fda fast track nda abraxane fda fast track nnda abraxane fda fast track ndda abraxane fda fast track ndaa abraxane fda fast track nda abraxane fda fast track nda aabraxane fda fast track nda abbraxane fda fast track nda abrraxane fda fast track nda abraaxane fda fast track nda abraxxane fda fast track nda abraxaane fda fast track nda abraxanne fda fast track nda abraxanee da fast track nda abraxane fa fast track nda abraxane fd fast track nda abraxane fdafast track nda abraxane fda ast track nda abraxane fda fst track nda abraxane fda fat track nda abraxane fda fas track nda abraxane fda fasttrack nda abraxane fda fast rack nda abraxane fda fast tack nda abraxane fda fast trck nda abraxane fda fast trak nda abraxane fda fast trac nda abraxane fda fast tracknda abraxane fda fast track da abraxane fda fast track na abraxane fda fast track nd abraxane fda fast track ndaabraxane fda fast track nda braxane fda fast track nda araxane fda fast track nda abaxane fda fast track nda abrxane fda fast track nda abraane fda fast track nda abraxne fda fast track nda abraxae fda fast track nda abraxan f da fast track nda abraxane fd a fast track nda abraxane fda fast track nda abraxane fda fast track nda abraxane fda f ast track nda abraxane fda fa st track nda abraxane fda fas t track nda abraxane fda fast track nda abraxane fda fast track nda abraxane fda fast t rack nda abraxane fda fast tr ack nda abraxane fda fast tra ck nda abraxane fda fast trac k nda abraxane fda fast track nda abraxane fda fast track nda abraxane fda fast track n da abraxane fda fast track nd a abraxane fda fast track nda abraxane fda fast track nda abraxane fda fast track nda a braxane fda fast track nda ab raxane fda fast track nda abr axane fda fast track nda abra xane fda fast track nda abrax ane fda fast track nda abraxa ne fda fast track nda abraxan e fda fast track nda abraxane dfa fast track nda abraxane fad fast track nda abraxane fd afast track nda abraxane fdaf ast track nda abraxane fda afst track nda abraxane fda fsat track nda abraxane fda fats track nda abraxane fda fas ttrack nda abraxane fda fastt rack nda abraxane fda fast rtack nda abraxane fda fast tarck nda abraxane fda fast trcak nda abraxane fda fast trakc nda abraxane fda fast trac knda abraxane fda fast trackn da abraxane fda fast track dna abraxane fda fast track nad abraxane fda fast track nd aabraxane fda fast track ndaa braxane fda fast track nda baraxane fda fast track nda arbaxane fda fast track nda abarxane fda fast track nda abrxaane fda fast track nda abraaxne fda fast track nda abraxnae fda fast track nda abraxaen afda fast track nda abraxane thefda fast track nda abraxane fda fast track nda abraxane
a  b  c  d  e  f  g  h  i  k  l  m  n  o  p  r  s  t  u  v  w  x  z 

Copyright 2005 D-S LTD.
All Rights Reserved.